IL159876A0 - Controlled drug delivery systems providing variable release rates - Google Patents

Controlled drug delivery systems providing variable release rates

Info

Publication number
IL159876A0
IL159876A0 IL15987602A IL15987602A IL159876A0 IL 159876 A0 IL159876 A0 IL 159876A0 IL 15987602 A IL15987602 A IL 15987602A IL 15987602 A IL15987602 A IL 15987602A IL 159876 A0 IL159876 A0 IL 159876A0
Authority
IL
Israel
Prior art keywords
drug delivery
delivery systems
release rates
controlled drug
systems providing
Prior art date
Application number
IL15987602A
Other languages
English (en)
Original Assignee
Phoqus Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoqus Pharmaceuticals Ltd filed Critical Phoqus Pharmaceuticals Ltd
Publication of IL159876A0 publication Critical patent/IL159876A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15987602A 2001-07-19 2002-07-18 Controlled drug delivery systems providing variable release rates IL159876A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0117618.9A GB0117618D0 (en) 2001-07-19 2001-07-19 Pharmaceutical dosage form
PCT/GB2002/003286 WO2003007919A1 (en) 2001-07-19 2002-07-18 Controlled drug delivery systems providing variable release rates

Publications (1)

Publication Number Publication Date
IL159876A0 true IL159876A0 (en) 2004-06-20

Family

ID=9918808

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15987602A IL159876A0 (en) 2001-07-19 2002-07-18 Controlled drug delivery systems providing variable release rates

Country Status (14)

Country Link
US (1) US20060099257A1 (de)
EP (1) EP1406597A1 (de)
JP (2) JP2005501039A (de)
KR (1) KR20040032857A (de)
CN (1) CN1556697A (de)
AU (1) AU2002317360B2 (de)
BR (1) BR0211156A (de)
CA (1) CA2457308A1 (de)
GB (1) GB0117618D0 (de)
IL (1) IL159876A0 (de)
MX (1) MXPA04000544A (de)
RU (1) RU2004104950A (de)
WO (1) WO2003007919A1 (de)
ZA (1) ZA200401216B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002333644A1 (en) 2001-09-17 2003-04-01 Glaxo Group Limited Dry powder medicament formulations
TW200517127A (en) * 2003-08-07 2005-06-01 Sb Pharmco Inc Novel composition
AR046410A1 (es) 2003-09-18 2005-12-07 Cephalon Inc Composiciones farmaceuticas para la liberacion modificada de modafinilo
CA2540059C (en) * 2003-09-26 2013-08-06 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
AU2004275816A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
ATE504288T1 (de) * 2003-09-26 2011-04-15 Alza Corp Oros-push-stick für die kontrollierte abgabe von wirkstoffen
ATE544447T1 (de) * 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US7390524B1 (en) 2004-05-20 2008-06-24 Advanced Cardiovascular Systems, Inc. Method for electrostatic spraying of an abluminal stent surface
NZ552841A (en) * 2004-08-04 2009-07-31 Alza Corp Controlled release dosage form comprising two layers, wherein the delay layer is substanially free of non-microencapsulated drug
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8022032B2 (en) 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
US20070259930A1 (en) * 2006-04-10 2007-11-08 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
ES2379117T3 (es) 2006-05-16 2012-04-20 Knopp Neurosciences, Inc. Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas
EP2465500A1 (de) 2006-05-16 2012-06-20 Knopp Neurosciences, Inc. Therapeutisch wirksame Mengen von R(+) und S(-)-Pramipexol zur Verwendung bei der Behandlung von Parkinson
JP5410964B2 (ja) * 2006-05-23 2014-02-05 オラヘルス コーポレーション 付着性アカシアゴムを含む二層構造の口腔内付着錠
US8524695B2 (en) * 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) * 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク． キラル精製置換ベンゾチアゾールジアミンの合成
WO2009122431A2 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd., Oral controlled release tablet
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
US8343524B2 (en) 2008-07-31 2013-01-01 Clarke Mosquito Control Products, Inc. Extended release tablet and method for making and using same
WO2010017821A1 (en) * 2008-08-14 2010-02-18 Daniel Bar-Shalom Coated tablets with a remaining degradation surface over the time8
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
WO2010148409A1 (en) * 2009-06-19 2010-12-23 Knopp Neurosciences, Inc. Compositions and methods for treating amyotrophic lateral sclerosis
US20120070465A1 (en) 2010-03-29 2012-03-22 Astellas Pharma Inc. Pharmaceutical composition for modified release
EP2481411A1 (de) * 2011-01-27 2012-08-01 Ratiopharm GmbH Orale Dosierformen für modifizierte Freisetzung mit dem JAK3-Hemmer tasocitinib
LT5850B (lt) 2011-08-31 2012-07-25 Česlovas Paplauskas Vertikalaus srauto išorinis fazės apgręžiklis garso monitoriams
US8697118B2 (en) * 2011-10-18 2014-04-15 St. Teresa Medical, Inc. Stabilizers for hemostatic products
EP4035683A1 (de) 2011-12-12 2022-08-03 Adare Pharmaceuticals USA, Inc. Partikelformulierungen mit verzögerter freisetzung
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
LT3019167T (lt) 2013-07-12 2021-03-25 Knopp Biosciences Llc Eozinofilų ir (arba) bazofilų padidintų kiekių gydymas
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
AU2014306597B2 (en) 2013-08-13 2018-05-17 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
EP3038467B1 (de) 2013-08-13 2020-07-29 Knopp Biosciences LLC Zusammensetzungen und verfahren zur behandlung von plasmazellenerkrankungen und prolymphozytischen b-zellen-erkrankungen
WO2015117004A1 (en) * 2014-01-31 2015-08-06 Board Of Regents, The University Of Texas System Method for preparing films
KR20180014778A (ko) 2015-06-03 2018-02-09 트리아스텍 인코포레이티드 제형 및 이의 용도
KR20230157528A (ko) 2017-01-26 2023-11-16 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
CN115645374B (zh) * 2022-12-25 2024-04-26 山东理工职业学院 一种硫酸沙丁胺醇片的制备方法
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
GB2253164B (en) * 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
ATE293440T1 (de) * 1995-05-09 2005-05-15 Phoqus Pharmaceuticals Ltd Pulverbeschichtungszusammensetzung für elektrostatische beschichtung von pharmazeutischen substraten
MXPA01010377A (es) * 1999-04-13 2002-10-23 Beecham Pharm Pte Ltd Metodo novedoso de tratamiento.

Also Published As

Publication number Publication date
EP1406597A1 (de) 2004-04-14
CN1556697A (zh) 2004-12-22
MXPA04000544A (es) 2005-06-06
JP2005501039A (ja) 2005-01-13
GB0117618D0 (en) 2001-09-12
RU2004104950A (ru) 2005-03-10
WO2003007919A1 (en) 2003-01-30
BR0211156A (pt) 2004-08-10
CA2457308A1 (en) 2003-01-30
US20060099257A1 (en) 2006-05-11
KR20040032857A (ko) 2004-04-17
AU2002317360B2 (en) 2006-08-17
ZA200401216B (en) 2005-03-17
JP2005519858A (ja) 2005-07-07

Similar Documents

Publication Publication Date Title
IL159876A0 (en) Controlled drug delivery systems providing variable release rates
HUP0401438A3 (en) Drug delivery system
HUP0500795A3 (en) Gastric retention controlled drug delivery system
MXPA03009727A (es) SISTEMA DE SUMINISTRO DE FaRMACOS DE LIBERACIoN PROLONGADA QUE CONTIENE COFARMACOS.
TWI350176B (en) Controlled release delivery system for nasal applications
HK1077523A1 (en) Proliposomal drug delivery system
EP1379291A4 (de) Integriertes medikamentenabgabesystem
GB2421689B (en) Drug delivery system
IL155272A0 (en) Systems for optimized drug delivery
GB0123633D0 (en) Stent delivery system
IL159875A0 (en) Zero order controlled drug delivery system
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
EP1411905A4 (de) Abgabesystem mit verzögerter freisetzung
AU2003288608A8 (en) Controlled release, multiple unit drug delivery systems
GB0103877D0 (en) Novel Drug Delivery system
MXPA03007124A (es) Sistemas para el suministro de farmaco con objetivo anti-tumor.
GB0100115D0 (en) Delivery systems
GB0102725D0 (en) Medical delivery system
AU2002304394A1 (en) Controlled release drug delivery device
AU2002246571A1 (en) Drug delivery systems
GB0115136D0 (en) Drug delivery system
GB0112326D0 (en) Drug delivery system
AUPR567801A0 (en) Delivery controlled systems
AU2002228323A1 (en) Spaced drug delivery system
GB0113857D0 (en) Delivery system